Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street ...

Amedisys (AMED) delivered earnings and revenue surprises of 10.62% and 0%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Reports Q1 revenue $594.8M, consensus $596.49M.Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported first-quarter earnings of $61 million. On a per-share basis, the Baton Rouge, Louisiana-based company said it ...

A federal judge in Maryland ordered the Justice Department and UnitedHealth Group to begin mediation on Aug. 18.

UnitedHealth, Amedisys and antitrust regulators will have a magistrate judge’s help in hashing out a solution to the DOJ’s ...

The U.S. Department of Justice’s (DOJ) lawsuit against Amedisys Inc. (NASDAQ: AMED) and UnitedHealth Group (NYSE: UNH) will ...

BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Net service revenue increased ...

The Department of Justice will head to mediation with UnitedHealth Group and Amedisys April 18 as part of an ongoing antitrust lawsuit. Both companies are attempting to finalize a $3.3 billion ...

Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Sell-side analysts expect that Amedisys will post 4.4 earnings per share for the current year. Hedge Funds Weigh In On Amedisys ...